Concepedia

Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis

Roberto Padoan, Fulvia Chieco Bianchi, Maria Rita Marchi, Diego Cazzador, Mara Felicetti, Enzo Emanuelli, Andrea Vianello, Piero Nicolai, Andrea Doria, Franco Schiavon

The Journal of Allergy and Clinical Immunology In Practice · 2020 · 36 citations · 6 references

DOI

Concepts

References

6

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. Charles Jennette, Ronald J. Falk, P. A. Bacon et al. · Arthritis & Rheumatism · 2012 · 6.6K citations · Full text

, , +16

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Eugene R. Bleecker, J. Mark FitzGerald, Pascal Chanez et al. · The Lancet · 2016 · 1.4K citations

, , +13

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Michael E. Wechsler, Praveen Akuthota, David Jayne et al. · New England Journal of Medicine · 2017 · 1.1K citations · Full text

, , +16

Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

Cloé Comarmond, Christian Pagnoux, Mehdi Khellaf et al. · Arthritis & Rheumatism · 2012 · 915 citations

, , +13

Increased production of IL-5 and dominant Th2-type response in airways of Churg–Strauss syndrome patients

Bogdan Jakieła, Wojciech Szczeklik, Hanna Plutecka et al. · Lara D. Veeken · 2012 · 122 citations · Full text

, , +17